Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Dr Reddys Laboratories

RDY

----

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Weekly Recap | Twist Bioscience +3.19%, consensus target below spot
Weekly Review·7 hours ago
TWST+0.33%
Weekly Recap | Alnylam Pharma -14.16%, one-way selling
Weekly Review·7 hours ago
ALNY-4.96%
Weekly Recap | RXRX.US +10.16%, most brokers rate it buy
Weekly Review·8 hours ago
RXRX+1.23%
Weekly Recap | Roche -4.04%, most brokers rate it buy
Weekly Review·8 hours ago
RHHBY-0.19%
Weekly Recap | PURR.US -7.47%, consensus target above spot
Weekly Review·8 hours ago
PURR-1.16%
Weekly Recap | Kodiak Sciences +191.96%, Zenkuda hits phase 3 goal
Weekly Review·8 hours ago
KOD-4.07%
Weekly Recap | BioNTech SE this week, CEO trims shares repeatedly
Weekly Review·9 hours ago
BNTX+0.05%
Weekly Recap | ABSI.US +13.66%, most brokers rate it buy
Weekly Review·9 hours ago
ABSI+2.98%
Weekly Recap | SPDR S&P Biotech -0.39%, busy week of biotech headlines
Weekly Review·10 hours ago
XBI-0.05%
Weekly Recap | ARKG.US +1.2%, closing in on record highs
Weekly Review·11 hours ago
ARKG+1.56%
Novo Nordisk AS files trademark opposition against Dr. Reddy's Olymviq
Wallstreetcn·Mar 25 at 01:36 PM
PBE-0.03%NVO-0.21%